🟢 West Pharmaceutical Services is trading 6.1% up in pre-market with no clear new catalyst

West Pharmaceutical Services is trading at $432.82, up 6.11% versus the November 2 close; no clear catalyst has been identified.

• Third-quarter revenue was $874.5 million and adjusted EPS was $2.66; the company then raised its 2026 revenue and adjusted EPS guidance.
• The reported earnings reaction occurred October 29, so its connection to this pre-market move is uncertain.
• Supplied market context is mixed and does not clearly explain the rise.